Early Access — free while we kick the tires
EdgarHawk

Levy Susan Cohen

EVP and General Counsel

Officer
2 filings analyzed · 1 company · Latest 2025-11-05

Companies

Company Buys Sells Direction
NORTHERN TRUST CORP NTRS 0 5 Net selling

Activity

November 2025
2025-11-05 NORTHERN TRUST CORP NTRS
medium
Sell
27,591 shares
$3,535,326
Significance 5/10

Susan Cohen, EVP/General Counsel, sold 27,591 shares at $128.13 avg for $3.5M, reducing stake by 36.4%.

Levy Susan Cohen executed 2 separate sales totaling 27,591 shares for $3,535,325.86, reducing her NTRS holdings from 75,848 to 48,257 shares. At current price of $128.19 and 52-week range of $84.45–$134.60, the transaction occurred near the upper band of recent trading. Her prior sell at this ticker on 2024-10-25 returned +7.0% over 30 days and +7.1% over 90 days—poorly timed for exit, as the stock rose after the sale. The company shows solid fundamentals: $2,025,400,000 in latest quarterly revenue, net income of $457,600,000, annual revenue growth of +22.4%, and P/E of 14.04. Without scheduling information (10b5-1 plan or otherwise), the discretionary nature of this 36.4% reduction at elevated valuation levels warrants investor attention, though the magnitude of remaining holdings (48,257 shares) and fundamentals do not signal distress.

October 2024
2024-10-29 NORTHERN TRUST CORP NTRS
high
Sell
19,585 shares
$2,002,762
Significance 5/10

EVP & General Counsel Levy sold 19,585 shares of NTRS for $2.0M at $102.26 on 2024-10-25, reducing holdings by 53.3%.

Levy Susan Cohen executed a substantial reduction of her NTRS position, selling 19,585 shares (19.6K shares) on 2024-10-25 at $102.26, lowering her holdings from 36,717 shares (36.7K shares) to 17,132 shares (17.1K shares)—a net reduction of 53.3% of pre-transaction holdings. This sale occurred near the top of the 52-week range ($63.06–$102.79), with the stock at -0.5% from its 52-week high, and follows a strong 30-day (+13.6%) and 90-day (+15.4%) rally. Her cross-ticker track record shows 1 prior buy with average 90-day returns of +26.4%, and her single prior NTRS trade (a buy on 2023-10-24) was well-timed at the 90-day mark with +26.4% return, establishing a pattern of favorable entry timing. The current trade—a large discretionary sale of more than half her remaining position when the stock was near annual highs—stands in contrast to her demonstrated history of well-timed purchases and warrants close observation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access